Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab-Reference-Cited by-同舟云学术

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab

Published:2015-02 Issue:2 Volume:42 Page:78-84
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Lam Karen,Chan Conrad,Done Susan J.,Levine Mark N.,Reilly Raymond M.

Funder

Ontario Institute for Cancer Research [Smarter Imaging Program and High Impact Clinical Trial (HICT) Program]

Province of Ontario

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference23 articles.

1. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

3. HER2 therapy: molecular mechanisms of trastuzumab resistance;Nahta;Breast Cancer Res,2006

4. Molecular imaging as a tool for personalized and targeted anticancer therapy;McLarty;Clin Pharmacol Ther,2007

5. Herceptin: mechanisms of action and resistance;Nahta;Cancer Lett,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy;Frontiers in Medicine;2023-06-27

2. Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, ¹⁷⁷Lu;Molecular Pharmaceutics;2022-12-14

3. Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart;Pharmaceutics;2022-08-02

4. Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers;Frontiers in Pharmacology;2021-06-02

5. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice;Journal of Alzheimer's Disease;2020-08-18